If you are interested in exploring the new buzzword “Innovation”, or are already ahead of the game, at an early or late stage of commercialising your science, this event is for you.
We are delighted to announce that the lecture series on Health and Life Sciences Entrepreneurship will conclude with a FINAL panel discussion on Support for Innovators that will bring together the main innovation stakeholders within Oxford; representatives of dedicated teams that nurture the entrepreneurial ecosystem locally by providing a wealth of expertise and experience and an invaluable network of specialists and investors that will turn the challenge of building a business into a realistic possibility.
Find out what this support could do to you and to your prospective business by joining us on Wednesday the 10th of May 2017 at Lecture Theatre 1, the Academic Centre, Level 2, John Radcliffe Hospital.
This session is part of a series on entrepreneurship in health and life-sciences organised by Innovation Forum Oxford, in collaboration with the MRC Weatherall Institute of Molecular Medicine.
This lecture series is a part of the IMAGINE IF! accelerator programme, designed to inspire and foster grassroots innovation. The business idea competition provides support, mentorship and opportunity to secure $30,000 of non-diluted capital.
Note: If you are already registered for the complete lecture series there is no need to register again for this event. Please send any booking queries to [email protected].
Since 2013 Adam has been responsible for leading all life sciences commercialisation activities at Oxford University Innovation Ltd (OUI), the technology transfer company of the University of Oxford. In this role he has overseen the formation of more than 20 new spin out companies and recently led the creation of LAB282, a £13M partnership with Oxford Sciences Innovation plc and Evotec AG to accelerate Oxford drug discovery. He has worked for 15 years in the pharma/biotech sector in commercial roles encompassing business development and licensing, new venture formation, product development, lobbying/advocacy and general management. Between 2010 and 2013 Adam worked as Deputy General Manager for the Oxford-Emergent Tuberculosis Consortium Ltd, a joint venture between the University of Oxford and Emergent BioSolutions Inc, which raised more than $30M to conduct the first ever efficacy study of a next generation TB vaccine in infants. Prior to this Adam worked in healthcare consulting with Technomark Ltd and then in increasingly senior commercialisation roles at OUI.
Dr Victor Bolanos-Garcia is Senior Lecturer in Clinical Biochemistry, Knowledge Exchange and Impact Faculty Lead and member of the management team of the BioInnovation hub at Oxford Brookes University. He represents Oxford Brookes at the Oxford Academic Health Science Centre (OxAHSC), a new partnership with Oxford Health NHS Foundation Trust, Oxford University Hospitals NHS Trust, and the University of Oxford that combines the institutions’ individual strengths in basic science, translational research and clinical expertise to address 21st century healthcare challenges thus contributing to drive economic growth. He is also a member of the iCASE committee of the Doctoral Training Programme (DTP) funded by the BBSRC and run in partnership with The University of Oxford, The Pirbright Institute, Diamond Light Source (DLS), STFC Central Laser Facility and the ISIS Neutron Source.
Dr Bolanos-Garcia is a structural biologist who trained with Francisco Bolívar-Zapata (the creator of the plasmid pBR322, one of the first widely used E. coli cloning vectors) at the National Autonomous University of Mexico (UNAM), Ermanno Gherardi at the Laboratory of Molecular Biology of the Medical Research Council (LMB-MRC) and Prof. Sir Tom Blundell at the University of Cambridge. As a Wellcome Trust International Research Fellow, Bolanos-Garcia studied the mechanisms of cell proliferation and motility by the MET kinase receptor and initiated work on the spindle assembly checkpoint (SAC), the mechanism that ensures the accurate separation of the genetic material to an offspring every time a cell divides. Study of the SAC in the Bolanos-Garcia lab follows a multidisciplinary approach that combines X-ray protein crystallography, protein biochemistry and protein biophysics with chemioinformatics, molecular and cellular biology methods. As well as conducting basic research, Dr Bolanos-Garcia leads a programme of science directed towards improvements in human health through the development of innovative diagnosis and therapeutic approaches to tackle cancer, birth and development disorders resulting from chromosome separation defects.
Prior to joining MPLS, Anne worked for Innovate UK as Associate Director of ESKTN, leading their work on Sustainable Agriculture and Land Management, involved in the roll out of the UK’s Agri-Tech strategy. She represented the UK on EU steering groups concerned with sustainable biomass and bioenergy and the LWEC Ecosystem Task Force as the link person between research and business communities. She previously worked for the EEF, developing and delivering environmental training for industry in partnership with IEMA, the professional institute for environmental practitioners as well as working for 25 years as a lecturer in Environmental Sciences, where she developed and delivered a number of innovative MSc programmes in different institutions, in addition to research in ecotoxicology and pollution management.
Her current role entails developing and delivering a programme of enterprise activities and training for MPLS, having been initially responsible with her colleague Leah Thompson for the development of the enterprise portal, eship.ox.ac.uk, to support the development of the entrepreneurial ecosystem and enterprise culture across Oxford.
Dr. Thomas Hellmann is a Professor of Entrepreneurship and Innovation at the Saïd School of Business, University of Oxford, and the Academic Director of its Entrepreneurship Centre. He holds a BA from the London School of Economics and a PhD from Stanford University. He previously was faculty at the Graduate School of Business (Stanford), and at the Sauder School of Business (University of British Columbia). He also held visiting positions at Harvard Business School, Wharton, the Hoover Institution, INSEAD, and the University of New South Wales. He has taught numerous MBA, executive, and undergraduate courses in the areas of entrepreneurship, finance, and strategic management. His research focuses on entrepreneurial finance, entrepreneurship, innovation and public policy. His academic writings have been published in many leading economics, finance and management journals, including the American Economic Review, the Journal of Finance, and Management Science. He has been a consultant to a variety of clients, including the World Economic Forum and the Government of British Columbia. He wrote numerous case studies on entrepreneurial companies and venture financing. He is also the founder of the NBER Entrepreneurship Research Boot Camp.
Nick has over 25 years’ experience in commercial and business development in the life sciences sector both in executive positions in companies, such as PowderJect Pharmaceuticals plc, and as a consultant specialising in strategy, business development, finance and government affairs. He studied at Cambridge University and was awarded the MBE for services to biotechnology in 2001.
Dr Danuta Mariola Jeziorska is a Postdoctoral Research Scientist at the MRC Weatherall Institute of Molecular Medicine (WIMM) at the University of Oxford. Her research focuses on understanding how genes are turned on and off during red blood cell formation, with a particular interest on two aspects of this process: the dynamics of transcription at the single cell level and the role of DNA methylation. Before moving to Oxford, Danuta completed her PhD in Systems Biology from the University of Warwick and obtained a BSc degree in Biotechnology from the University of Silesia in Poland.
Danuta is passionate about combining her academic background with her strong interest in innovation and entrepreneurship. She is current leading the Oxford branch of the Innovation Forum, a non-profit global network that aims to accelerate innovation by inspiring and educating the next generation of entrepreneurs and strengthening connections between academics, industry and healthcare professionals. Danuta is also very passionate about supporting women in the academic and entrepreneurial ecosystems. She is a member of the directors board of TechTonic that aims to address the lack of support for women in the technology sector in Oxfordshire.
Wednesday, May 10th 2017
18:00 – 20:30 (GMT)
Lecture Theatre 1